NCT07387458

Brief Summary

This study will provide the first national overview of BTM and vitamin D utilization among healthcare professionals in Taiwan. The findings are expected to inform educational strategies, optimize clinical implementation, and support evidence-based policy development for osteoporosis management.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
432

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

January 20, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 4, 2026

Completed
Last Updated

February 4, 2026

Status Verified

November 1, 2025

Enrollment Period

1.1 years

First QC Date

January 20, 2026

Last Update Submit

January 27, 2026

Conditions

Vitamin DBone Remodeling

Outcome Measures

Primary Outcomes (2)

  • Bone formation marker

    Bone formation marker concentration

    The enrollment day

  • Vitamin D

    Vitamin D concentration

    The enrollment day

Study Arms (1)

Healthcare professionals

Healthcare professionals participating in osteoporosis-related courses

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthcare professionals participating in osteoporosis-related courses

You may qualify if:

  • \- Healthcare professionals participating in osteoporosis-related courses

You may not qualify if:

  • Diseases that may affect bone metabolism, such as cancer, stroke, or mobility impairment
  • Use of medications that significantly affect bone metabolism, such as selective estrogen receptor modulators, bisphosphonates, denosumab, anabolic agents, or estrogen

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taiwanese Osteoporosis Association

Tainan, Taiwan

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

calcium, phosphate, albumin, creatinine (Cr), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and serum 25-hydroxyvitamin D \[25(OH)D\], iPTH, CTX, osteocalcin

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 20, 2026

First Posted

February 4, 2026

Study Start

December 1, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

February 4, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations

TW(1)